These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Erhardt P; Schremser EJ; Cooper GM Mol Cell Biol; 1999 Aug; 19(8):5308-15. PubMed ID: 10409722 [TBL] [Abstract][Full Text] [Related]
7. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras. Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015 [TBL] [Abstract][Full Text] [Related]
8. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta. Wert MM; Palfrey HC Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070 [TBL] [Abstract][Full Text] [Related]
9. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Sheng H; Shao J; Dubois RN Cancer Res; 2001 Mar; 61(6):2670-5. PubMed ID: 11289146 [TBL] [Abstract][Full Text] [Related]
10. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367 [TBL] [Abstract][Full Text] [Related]
12. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells. Yuen HF; Abramczyk O; Montgomery G; Chan KK; Huang YH; Sasazuki T; Shirasawa S; Gopesh S; Chan KW; Fennell D; Janne P; El-Tanani M; Murray JT Biosci Rep; 2012 Aug; 32(4):413-22. PubMed ID: 22668349 [TBL] [Abstract][Full Text] [Related]
13. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897 [TBL] [Abstract][Full Text] [Related]
14. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206 [TBL] [Abstract][Full Text] [Related]
15. Thrombin-stimulated cell proliferation mediated through activation of Ras/Raf/MEK/MAPK pathway in canine cultured tracheal smooth muscle cells. Lin CC; Shyr MH; Chien CS; Wang CC; Chiu CT; Hsiao LD; Yang CM Cell Signal; 2002 Mar; 14(3):265-75. PubMed ID: 11812655 [TBL] [Abstract][Full Text] [Related]
16. Human alphaA- and alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK and AKT signaling pathways. Liu JP; Schlosser R; Ma WY; Dong Z; Feng H; Liu L; Huang XQ; Liu Y; Li DW Exp Eye Res; 2004 Sep; 79(3):393-403. PubMed ID: 15336502 [TBL] [Abstract][Full Text] [Related]
17. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. Shin I; Kim S; Song H; Kim HR; Moon A J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464 [TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034 [TBL] [Abstract][Full Text] [Related]
19. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425 [TBL] [Abstract][Full Text] [Related]
20. Role of mitogen-activated protein kinases in the induction of parathyroid hormone-related peptide. Aklilu F; Gladu J; Goltzman D; Rabbani SA Cancer Res; 2000 Mar; 60(6):1753-60. PubMed ID: 10749150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]